Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients With Parkinson's Disease

Clinical trial NCT06659562 · COMPLETED

Trial details

NCT number: NCT06659562
Sponsor: Herantis Pharma Plc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease, Idiopathic

Start date: 2024-09-23
Primary completion: 2025-08-14
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.